Scott Lundahl

USPTO Granted Patents = 21 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 3

Average Co-Inventor Count = 1.9

ph-index = 9

Forward Citations = 306(Granted Patents)

Location History:

Wilmington, MA (US) (2016 - 2018)
Lexington, MA (US) (2001 - 2023)

Company Filing History:

20 out of 44

Dusa Pharmaceuticals, Inc.

patents

1 out of 149

Sun Pharmaceutical Industries Limited

patents

Years Active: 2001-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12296011 - Methods for photodynamic therapy (2025-05-13),

2. 11690914 - Methods for photodynamic therapy (2023-07-04),

3. 11571478 - Methods for photodynamic therapy (2023-02-07),

4. 11135293 - Methods for photodynamic therapy (2021-10-05),

5. 11077192 - Methods for photodynamic therapy (2021-08-03),

6. 10357567 - Methods for photodynamic therapy (2019-07-23),

7. 10029116 - Method for the treatment of acne (2018-07-24),

8. 9723991 - Illuminator for photodynamic therapy (2017-08-08),

9. 9597150 - Method for the permanent removal of hair (2017-03-21),

10. 9561276 - Method of treating onychomycosis (2017-02-07),

11. 9387341 - Method for the treatment of acne (2016-07-12),

12. 9339540 - Method of treating onychomycosis (2016-05-17),

13. 9241957 - Compositions and methods for reducing photosensitivity associated with photodynamic therapy (2016-01-26),

14. 8758418 - Illuminator for photodynamic therapy (2014-06-24),

15. 8609073 - Compositions and methods for reducing photosensitivity associated with photodynamic therapy (2013-12-17),

Title: Innovations in Photodynamic Therapy: The Contributions of Scott Lundahl

Introduction: Scott Lundahl is a prominent inventor based in Lexington, MA, recognized for his significant contributions to the field of photodynamic therapy. With an impressive portfolio of 20 patents, he has made notable strides in enhancing treatment methods that improve patient care and outcomes.

Latest Patents: Among his latest groundbreaking patents, Scott has developed a method for enhancing the penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy. This innovative method involves the topical application of ALA to the treatment area, followed by the coverage of the area with a low-density polyethylene barrier. This barrier effectively minimizes transepidermal water loss before light treatment, optimizing the therapy's efficacy.

Career Highlights: Scott has dedicated his career to advancing photodynamic therapy techniques, particularly through his work at Dusa Pharmaceuticals, Inc. His expertise and innovative approaches have positioned him as a leader in this specialized field, helping to pioneer methods that significantly enhance patient experiences and treatment success rates.

Collaborations: Throughout his career, Scott has collaborated with talented professionals such as Rebecca Kozodoy and Ronald Carroll. These collaborations have been instrumental in driving the research and development processes, contributing to the success of the inventions and patents stemming from their collective efforts.

Conclusion: Scott Lundahl's commitment to innovation in photodynamic therapy exemplifies the impact that determined inventors can have on the medical field. His patents not only showcase his innovative spirit but also reflect a dedication to improving therapeutic techniques that benefit countless patients. As he continues to develop new methods, the future of photodynamic therapy looks promising.

This text is generated by artificial intelligence and may not be accurate.